K5t7S
K5t7S
K5t7S
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
286. Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and<br />
triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.<br />
Arch Gen Psychiatry. 1993;50(5):387-93.<br />
287. Siwek M, Dudek D, Paul IA, Sowa-Kucma M, Zieba A, Popik P, et al. Zinc supplementation<br />
augments efficacy of imipramine in treatment resistant patients: a double blind, placebocontrolled<br />
study. J Affect Disord. 2009;118(1-3):187-95.<br />
288. Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Canadian Network for Mood and Anxiety<br />
Treatments (CANMAT). Clinical guidelines for the treatment of depressive disorders. IV.<br />
Medications and other biological treatments. Can J Psychiatry. 2001;46 Suppl 1:38S-58S.<br />
289. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients’ perspectives on<br />
electroconvulsive therapy: systematic review. BMJ. 2003;326(7403):1363.<br />
290. Dunne RA, McLoughlin DM. Systematic review and meta-analysis of bifrontal<br />
electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in<br />
depression. World J Biol Psychiatry. 2012;13(4):248-58.<br />
291. National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health:<br />
Clinical management and service guidance. London: NICE; 2007.<br />
292. Geddes J, Carney S, Cowen P, Goodwin G, Rogers R, Dearness K, et al. Efficacy and safety<br />
of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.<br />
Lancet. 2003;361(9360):799-808.<br />
293. Navarro V, Gasto C, Torres X, Masana G, Penades R, Guarch J, et al. Continuation/maintenance<br />
treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic<br />
depression: a two-year randomized study. Am J Geriat Psychiat. 2008;16(6):498-505.<br />
294. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, et al.<br />
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major<br />
depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy<br />
(CORE). Arch Gen Psychiatry. 2006;63(12):1337-44.<br />
295. Grunhaus L, Hirschman S, Dolberg OT, Schreiber S, Dannon PN. Coadministration of<br />
melatonin and fluoxetine does not improve the 3-month outcome following ECT. J ECT.<br />
2001;17(2):124-8.<br />
296. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, et al. Continuation<br />
pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a<br />
randomized controlled trial. JAMA. 2001;285(10):1299-307.<br />
297. Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, et al. Relapse prevention<br />
by means of paroxetine in ECT-treated patients with major depression: a comparison<br />
with imipramine and placebo in medium-term continuation therapy. Acta Psychiat Scand.<br />
1996;94(4):241-51.<br />
298. van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML. Efficacy<br />
and safety of continuation and maintenance electroconvulsive therapy in depressed elderly<br />
patients: a systematic review. Am J Geriatr Psychiatry. 2012;20(1):5-17.<br />
299. Serra M, Gasto C, Navarro V, Torres X, Blanch J, Masana G. Tratamiento electroconvulsivo<br />
de mantenimiento en la depresión unipolar psicótica del anciano. Med Clin (Barc).<br />
2006;126(13):491-2.<br />
300. Ramani R. Vagus nerve stimulation therapy for seizures. J Neurosurg Anesthesiol.<br />
2008;20(1):29-35.<br />
Guía de Práctica Clínica sobre el manejo de la depresión en el adulto 255